Navigation Links
Midwest angel investment in life sciences on the rise

Last year, I wrote about the emergence of some new angel groups in Illinois as well as the emergence of a number of new VCs and funds focused on early stage funding. I have been struck by the continued increase in this trend.

There is good reason for this as most of the Midwests biotech companies are early stage in comparison to their eas......

Full article >>> l funds managing about $175 billion.

These funds invest between $30 and $35 billion annually in entrepreneurial activity and bankroll less than 3,000 companies per year. Many of the financings are for companies already in their portfolios.

A typical VC round of funding is for a later-stage deal where they are investing between $10 and $15 million, according to Sohl. This creates ......

Full article >>> ndustry sectors.

3) Operational Angels: This group brings industry experience and expertise to the table but from large and established companies. These people may lack firsthand experience in the problems of a start-up.

4) Financial Angels: This final group invests purely for the financial return.

In biotech, I would add that there is a fifth group, which ......

Full article >>> owing 14 percent to 20 percent per year versus pension fund growth of only 8 percent per year. The key issue with angel investors is that they must be in a position to lose the entire investment or lose access to it for an extended period of time.

New companies created 20 million new jobs between 1979 and 1993 (or 67 percent of total job creation) with an additional 12 million jobs create......

Full article >>> may check out this trend throughout the Midwest. By the way, in its first event for the year, the Illinois Biotech Industry Organization (IBIO) will explore some of these angel groups and their activities in the life sciences at the University of Illinois at Chicago on February 25.

BIO Notes


On another note, I saw an article buried in last weeks Chicago Tribune. It mentione......

Full article >>> Network, LLC. (WTN). WTN, LLC accepts no legal liability or responsibility for any claims made or opinions expressed herein.......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 01/17/05


Related biology technology :

1. Midwest life science stocks kept sizzling in Q2
2. Midwest life science stocks sizzle in a tepid first quarter
3. A Midwest passage to India, Part II
4. Midwest offers non-stop flight to North Carolina research park
5. A Midwest life-science odyssey comes full circle
6. Midwest hotter for healthcare investments
7. A Midwest small-cap, life-science surprise package
8. 2006: A mixed blessing for Midwest life science companies
9. Midwest gaining stature in nanotech research
10. Midwest colleges strong contenders for NIH funds
11. Japan on the rebound: Implications for Midwest
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... RADNOR, Pa., Feb. 24, 2017  VWR Corporation (NASDAQ: VWR), ... to laboratory and production customers, today reported its financial results ... 2016. Highlights: 4Q16 record ... up 1.0% on an organic basis. ... on an organic basis, while the Americas net sales increased ...
(Date:2/23/2017)... Financial ... data, unaudited)Three Months Ended December 31,Twelve Months Ended December ... $           300$ ... Net Product Revenue 3539(10)%9498(4)%Kuvan Net ... Revenue  756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced ... for two key immunotherapy technologies from the University ... provides a method to monitor a patient for ... PD-L1 and CTLA-4.  The second license extends the ... patient is likely to have an immune-related adverse ...
(Date:2/23/2017)... Feb. 23, 2017  Imanis Life Sciences announced ... of oncolytic vaccinia viruses for virotherapy research. These ... of Genelux,s proprietary, vaccinia virus-based technology platform for ... enter into a partnership with Genelux to offer ... viruses for use in research," said Dr. ...
Breaking Biology Technology:
(Date:2/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... the LEERINK Partners 6th Annual Global Healthcare Conference at ... 15, 2017 at 10 a.m. Eastern Time. ... accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will be ... Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:1/30/2017)... FRANCISCO , Jan. 30, 2017   Invitae ... the fastest growing genetic information companies, today announced that ... financial results and provide 2017 guidance on Monday, February ... conference call that day at 4:45 p.m. Eastern / ... Invitae,s management team will briefly review financial results, guidance, ...
Breaking Biology News(10 mins):